.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
US Department of Justice
Farmers Insurance
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
Johnson and Johnson
McKesson
Deloitte

Generated: November 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lapatinib ditosylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharms Corp
TYKERB
lapatinib ditosylate
TABLET;ORAL022059NDANovartis Pharmaceuticals Corporation0078-0671-19150 TABLET in 1 BOTTLE (0078-0671-19)
Novartis Pharms Corp
TYKERB
lapatinib ditosylate
TABLET;ORAL022059NDAGlaxoSmithKline LLC0173-0752-00150 TABLET in 1 BOTTLE (0173-0752-00)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
McKesson
Baxter
Federal Trade Commission
Deloitte
Medtronic
Novartis
Accenture
Boehringer Ingelheim

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot